September 15, 2026 Imvax Announces Additional Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM and Provides Update on Planned Clinical Development
September 15, 2026 Empery Digital Sends Letter to Shareholders Detailing Efforts to Maximize Long-Term Value Creation for Shareholders
